KYTX
Kyverna Therapeutics, Inc. · Healthcare
Insider Buying
$2.0M
reported purchases (SEC code P)
Insider Selling
$293K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
May 29, 2026
Westlake BioPartners Opportunity Fund I, L.P.
Kyverna Therapeutics, Inc. (KYTX) has 14 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 29, 2026.
Inside the rolling window, 3 insiders at Kyverna Therapeutics, Inc. reported 2 open-market purchases totaling $2.0M and 1 open-market sale totaling $293K. Insiders have net bought $1.7M over the trailing 6 months. The most recent open-market filing is a purchase of 133,333 shares by 10% Owner Westlake BioPartners Opportunity Fund I, L.P., dated Dec 18, 2025, worth $1000K.
- Industry:Biotechnology
- CEO:Warner Biddle
- Employees:149
- HQ:Emeryville, CA, US
- IPO:2024-02-09
| Source | |||||||
|---|---|---|---|---|---|---|---|
Westlake BioPartners Opportunity Fund I, L.P.First filing | 10% Owner | Purchase | 133,333 | $1000K | Dec 22 | +5.9% | SEC ↗ |
SEIDENBERG BETH CFirst filing | Director | Purchase | 133,333 | $1000K | Dec 22 | +5.9% | SEC ↗ |
Walker Karen MarieFirst filing | Chief Technology Officer | Sale | 23,998 | $293K | Dec 17 | +24.6% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does KYTX have?
Kyverna Therapeutics, Inc. (KYTX) has 14 SEC Form 4 filings (16 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: May 29, 2026.
When was the most recent SEC Form 4 filing for KYTX?
The most recent Form 4 filing for KYTX on Tracefour is dated May 29, 2026.
What is the net insider flow at KYTX over the last 6 months?
Over the trailing 180 days, insiders at KYTX have net bought $1.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at KYTX in the current window?
Inside the rolling window, insiders at KYTX bought $2.0M and sold $293K based on SEC Form 4 filings.
Can I get alerts for KYTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Kyverna Therapeutics, Inc. (KYTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Kyverna Therapeutics, Inc. is in the Healthcare sector.